• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用电子病历数据对肝病患者风险调整方法的比较

Comparison of risk adjustment methods in patients with liver disease using electronic medical record data.

作者信息

Xu Yuan, Li Ning, Lu Mingshan, Dixon Elijah, Myers Robert P, Jolley Rachel J, Quan Hude

机构信息

Beijing YouAn Hospital, Capital Medical University, Beijing, China.

Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada.

出版信息

BMC Gastroenterol. 2017 Jan 7;17(1):5. doi: 10.1186/s12876-016-0559-4.

DOI:10.1186/s12876-016-0559-4
PMID:28061757
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5219741/
Abstract

BACKGROUND

Risk adjustment is essential for valid comparison of patients' health outcomes or performances of health care providers. Several risk adjustment methods for liver diseases are commonly used but the optimal approach is unknown. This study aimed to compare the common risk adjustment methods for predicting in-hospital mortality in cirrhosis patients using electronic medical record (EMR) data.

METHODS

The sample was derived from Beijing YouAn hospital between 2010 and 2014. Previously validated EMR extraction methods were applied to define liver disease conditions, Charlson comorbidity index (CCI), Elixhauser comorbidity index (ECI), Child-Turcotte-Pugh (CTP), model for end-stage liver disease (MELD), MELD sodium (MELDNa), and five-variable MELD (5vMELD). The performance of the common risk adjustment models as well as models combining disease severity and comorbidity indexes for predicting in-hospital mortality was compared using c-statistic.

RESULTS

Of 11,121 cirrhotic patients, 69.9% were males and 15.8% age 65 or older. The c-statistics across compared models ranged from 0.785 to 0.887. All models significantly outperformed the baseline model with age, sex, and admission status (c-statistic: 0.628). The c-statistics for the CCI, ECI, MELDNa, and CTP were 0.808, 0.825, 0.849, and 0.851, respectively. The c-statistic was 0.887 for combination of CTP and ECI, and 0.882 for combination of MELDNa score and ECI.

CONCLUSIONS

The liver disease severity indexes (i.e., CTP and MELDNa score) outperformed the CCI and ECI for predicting in-hospital mortality among cirrhosis patients using Chinese EMRs. Combining liver disease severity and comorbidities indexes could improve the discrimination power of predicting in-hospital mortality.

摘要

背景

风险调整对于有效比较患者的健康结局或医疗服务提供者的表现至关重要。几种用于肝脏疾病的风险调整方法通常被使用,但最佳方法尚不清楚。本研究旨在使用电子病历(EMR)数据比较预测肝硬化患者住院死亡率的常见风险调整方法。

方法

样本来自2010年至2014年期间的北京佑安医院。采用先前验证的EMR提取方法来定义肝脏疾病状况、查尔森合并症指数(CCI)、埃利克斯豪泽合并症指数(ECI)、Child-Turcotte-Pugh(CTP)、终末期肝病模型(MELD)、MELD钠(MELDNa)和五变量MELD(5vMELD)。使用c统计量比较常见风险调整模型以及结合疾病严重程度和合并症指数的模型预测住院死亡率的表现。

结果

在11121例肝硬化患者中,69.9%为男性,15.8%年龄在65岁及以上。比较模型的c统计量范围为0.785至0.887。所有模型均显著优于年龄、性别和入院状态的基线模型(c统计量:0.628)。CCI、ECI、MELDNa和CTP的c统计量分别为0.808、0.825、0.849和0.851。CTP和ECI组合的c统计量为0.887,MELDNa评分和ECI组合的c统计量为0.882。

结论

在使用中国EMR预测肝硬化患者住院死亡率方面,肝脏疾病严重程度指数(即CTP和MELDNa评分)优于CCI和ECI。结合肝脏疾病严重程度和合并症指数可提高预测住院死亡率的辨别能力。

相似文献

1
Comparison of risk adjustment methods in patients with liver disease using electronic medical record data.使用电子病历数据对肝病患者风险调整方法的比较
BMC Gastroenterol. 2017 Jan 7;17(1):5. doi: 10.1186/s12876-016-0559-4.
2
Development and Performance of an Algorithm to Estimate the Child-Turcotte-Pugh Score From a National Electronic Healthcare Database.一种从国家电子医疗数据库估算Child-Turcotte-Pugh评分的算法的开发与性能
Clin Gastroenterol Hepatol. 2015 Dec;13(13):2333-41.e1-6. doi: 10.1016/j.cgh.2015.07.010. Epub 2015 Jul 15.
3
Mortality after surgery in patients with liver cirrhosis: comparison of Child-Turcotte-Pugh, MELD and MELDNa score.肝硬化患者手术后的死亡率:Child-Turcotte-Pugh、MELD 和 MELDNa 评分的比较。
Eur J Gastroenterol Hepatol. 2011 Jan;23(1):51-9. doi: 10.1097/MEG.0b013e3283407158.
4
[Comparison of the prognostic value of mortality Child Pugh Score and forecasting models of chronic liver disease in patients with decompensated cirrhosis of the Hospital Nacional Cayetano Heredia, Lima-Peru].[秘鲁利马卡耶塔诺·埃雷迪亚国立医院失代偿期肝硬化患者中Child-Pugh评分与慢性肝病预测模型对死亡率的预后价值比较]
Rev Gastroenterol Peru. 2015 Oct-Dec;35(4):307-12.
5
Predictors of mortality in cirrhotic patients undergoing extrahepatic surgery: comparison of Child-Turcotte-Pugh and model for end-stage liver disease-based indices.接受肝外手术的肝硬化患者的死亡率预测因素:Child-Turcotte-Pugh评分与终末期肝病模型指数的比较
ANZ J Surg. 2014 Nov;84(11):832-6. doi: 10.1111/ans.12198. Epub 2013 May 6.
6
Predicting in-hospital mortality in patients with cirrhosis: results differ across risk adjustment methods.预测肝硬化患者的院内死亡率:不同风险调整方法的结果存在差异。
Hepatology. 2009 Feb;49(2):568-77. doi: 10.1002/hep.22676.
7
Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?纳入血清肌酐值能否改善Child-Turcotte-Pugh评分,并在肝硬化患者的短期预后评估中对终末期肝病模型评分的预后价值提出挑战?
Liver Int. 2004 Oct;24(5):465-70. doi: 10.1111/j.1478-3231.2004.0949.x.
8
Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.终末期肝病评分与血清钠比值指数模型作为肝硬化患者预后预测指标的验证
J Gastroenterol Hepatol. 2009 Sep;24(9):1547-53. doi: 10.1111/j.1440-1746.2009.05913.x. Epub 2009 Aug 3.
9
Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients.Child-Turcotte-Pugh评分与终末期肝病模型(MELD)评分在肝硬化患者择期和急诊手术后预后预测中的比较
Am J Surg. 2004 Nov;188(5):580-3. doi: 10.1016/j.amjsurg.2004.07.034.
10
A revised scope in different prognostic models in cirrhotic patients: Current and future perspectives, an Egyptian experience.肝硬化患者不同预后模型的修订范围:当前与未来展望,埃及的经验
Arab J Gastroenterol. 2013 Dec;14(4):158-64. doi: 10.1016/j.ajg.2013.08.007. Epub 2013 Sep 29.

引用本文的文献

1
Predictive scoring systems for in-hospital mortality due to acutely decompensated liver cirrhosis in Indonesia.印度尼西亚急性失代偿性肝硬化院内死亡率的预测评分系统。
BMC Gastroenterol. 2021 Oct 20;21(1):392. doi: 10.1186/s12876-021-01972-6.
2
Extra-hepatic comorbidity burden significantly increases 90-day mortality in patients with cirrhosis and high model for endstage liver disease.肝外合并症负担显著增加了肝硬化和终末期肝病模型评分高的患者的90天死亡率。
BMC Gastroenterol. 2020 Sep 16;20(1):302. doi: 10.1186/s12876-020-01448-z.
3
Comorbidities and Outcome of Alcoholic and Non-Alcoholic Liver Cirrhosis in Taiwan: A Population-Based Study.

本文引用的文献

1
Development and validation of method for defining conditions using Chinese electronic medical record.利用中国电子病历定义条件的方法的开发与验证
BMC Med Inform Decis Mak. 2016 Aug 20;16:110. doi: 10.1186/s12911-016-0348-6.
2
Changing trends of hospitalisation of liver cirrhosis in Beijing, China.中国北京肝硬化住院治疗的变化趋势
BMJ Open Gastroenterol. 2015 Aug 27;2(1):e000051. doi: 10.1136/bmjgast-2015-000051. eCollection 2015.
3
Estimation of Cancer Burden Attributable to Infection in Asia.亚洲因感染导致的癌症负担估计
台湾地区酒精性与非酒精性肝硬化的合并症及预后:一项基于人群的研究。
Int J Environ Res Public Health. 2020 Apr 20;17(8):2825. doi: 10.3390/ijerph17082825.
4
Development and Validation of a Model Consisting of Comorbidity Burden to Calculate Risk of Death Within 6 Months for Patients With Suspected Drug-Induced Liver Injury.构建一种包含合并症负担的模型,以计算疑似药物性肝损伤患者 6 个月内死亡风险的研究。
Gastroenterology. 2019 Nov;157(5):1245-1252.e3. doi: 10.1053/j.gastro.2019.07.006. Epub 2019 Jul 11.
5
A disease-specific comorbidity index for predicting mortality in patients admitted to hospital with a cardiac condition.用于预测因心脏疾病住院患者死亡率的疾病特异性合并症指数。
CMAJ. 2019 Mar 18;191(11):E299-E307. doi: 10.1503/cmaj.181186.
6
A Novel Prediction Model for Bloodstream Infections in Hepatobiliary-Pancreatic Surgery Patients.一种用于肝胆胰手术患者血流感染的新型预测模型。
World J Surg. 2019 May;43(5):1294-1302. doi: 10.1007/s00268-018-04903-x.
7
Potential savings in the treatment pathway of liver transplantation: an inter-sectorial analysis of cost-rising factors.肝移植治疗途径的潜在节省:成本上升因素的跨部门分析。
Eur J Health Econ. 2019 Mar;20(2):281-301. doi: 10.1007/s10198-018-0994-y. Epub 2018 Jul 26.
8
The effects of patient cost sharing on inpatient utilization, cost, and outcome.患者费用分担对住院利用率、成本和结果的影响。
PLoS One. 2017 Oct 26;12(10):e0187096. doi: 10.1371/journal.pone.0187096. eCollection 2017.
J Epidemiol. 2015;25(10):626-38. doi: 10.2188/jea.JE20140215. Epub 2015 Sep 19.
4
The Deyo-Charlson and Elixhauser-van Walraven Comorbidity Indices as predictors of mortality in critically ill patients.作为危重症患者死亡率预测指标的迪尤-查尔森和埃利克斯豪泽-范瓦尔雷文合并症指数
BMJ Open. 2015 Sep 8;5(9):e008990. doi: 10.1136/bmjopen-2015-008990.
5
Systematic review of risk adjustment models of hospital length of stay (LOS).住院时间(LOS)风险调整模型的系统评价。
Med Care. 2015 Apr;53(4):355-65. doi: 10.1097/MLR.0000000000000317.
6
Comparing the performance of the Charlson/Deyo and Elixhauser comorbidity measures across five European countries and three conditions.比较Charlson/Deyo共病测量法和Elixhauser共病测量法在五个欧洲国家及三种疾病情况下的表现。
Eur J Public Health. 2015 Feb;25 Suppl 1:15-20. doi: 10.1093/eurpub/cku221.
7
Correcting for optimistic prediction in small data sets.在小数据集上纠正乐观预测。
Am J Epidemiol. 2014 Aug 1;180(3):318-24. doi: 10.1093/aje/kwu140. Epub 2014 Jun 24.
8
Validation of the five-variable Model for End-stage Liver Disease (5vMELD) for prediction of mortality on the liver transplant waiting list.用于预测肝移植等候名单上死亡率的终末期肝病五变量模型(5vMELD)的验证
Liver Int. 2014 Sep;34(8):1176-83. doi: 10.1111/liv.12373. Epub 2013 Nov 20.
9
A comparison of electronic health records at two major Peking University Hospitals in China to United States meaningful use objectives.中国两所主要北京大学附属医院的电子健康记录与美国有意义使用目标的比较。
BMC Med Inform Decis Mak. 2013 Aug 28;13:96. doi: 10.1186/1472-6947-13-96.
10
Revision of MELD to include serum albumin improves prediction of mortality on the liver transplant waiting list.MELD 评分修订纳入血清白蛋白可改善肝移植等待名单上死亡率的预测。
PLoS One. 2013;8(1):e51926. doi: 10.1371/journal.pone.0051926. Epub 2013 Jan 18.